The Application of 3base™ Technology to Diagnose Eight of the Most Clinically Important Gastrointestinal Protozoan Infections
International Journal of Molecular Sciences · 29.08.2023 · 24 (17) · 13387
DOI: 10.3390/ijms241713387 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.08.2023. Verfasst von Mahdis Aghazadeh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Signatures, 7 Eliza Street, Newtown, NSW 2042, Australia. Hauptthemen laut MEDLINE: Cryptosporidiosis, Cryptosporidium, Gastrointestinal Diseases, Communicable Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Globally, over 3.5 billion people are infected with intestinal parasites each year, resulting in over 200,000 deaths. Three of the most common protozoan pathogens that affect the gastrointestinal tract of humans are Cryptosporidium spp., Giardia intestinalis, and Entamoeba histolytica. Other protozoan agents that have been implicated in gastroenteritis in humans include Cyclospora cayetanensis, Dientamoeba fragilis, Blastocystis hominis, and the microsporidia Enterocytozoon bieneusi and Encephalitozoon intestinalis. Genetic Signatures previously developed a 3base™ multiplexed Real-Time PCR (mRT-PCR) enteric protozoan kit (EP001) for the detection of Giardia intestinalis/lamblia/duodenalis, Cryptosporidium spp., E. histolytica, D. fragilis, and B. hominis. We now describe improvements to this kit to produce a more comprehensive assay, including C. cayetanensis, E. bieneusi, and E. intestinalis, termed EP005. The clinical performance of EP005 was assessed using a set of 380 clinical samples against a commercially available PCR test and other in-house nucleic acid amplification tests where commercial tests were not available. All methods provided at least 90% agreement. EP005 had no cross-reactivity against 82 organisms commonly found in the gut. The EP005 method streamlines the detection of gastrointestinal parasites and addresses the many challenges of traditional microscopic detection, resulting in cost savings and significant improvements in patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetic Signatures, 7 Eliza Street, Newtown, NSW 2042, Australia.
- Microbiology Department, Westmead Hospital, Westmead, NSW 2145, Australia.
- St. Vincent's Pathology, Level 6, Xavier Building, 390 Victoria Street, Darlinghurst, NSW 2010, Australia.
Zitieren
APA
Aghazadeh, M., Jones, M., Perera, S., Nair, J., Tan, L., Clark, B., Curtis, A., Jones, J., Ellem, J., Olma, T., Stark, D., Melki, J., Coulston, N., Baker, R., & Millar, D. (2023). The Application of 3base™ Technology to Diagnose Eight of the Most Clinically Important Gastrointestinal Protozoan Infections. International Journal of Molecular Sciences, 24(17), 13387. https://doi.org/10.3390/ijms241713387
Vancouver
Aghazadeh M, Jones M, Perera S, Nair J, Tan L, Clark B, et al. The Application of 3base™ Technology to Diagnose Eight of the Most Clinically Important Gastrointestinal Protozoan Infections. International Journal of Molecular Sciences. 2023;24(17):13387. doi:10.3390/ijms241713387
BibTeX
@article{Aghazadeh2023,
author = {Aghazadeh, Mahdis and Jones, Meghan and Perera, Suneth and Nair, Jiny and Tan, Litty and Clark, Brett and Curtis, Angela and Jones, Jackson and Ellem, Justin and Olma, Tom and Stark, Damien and Melki, John and Coulston, Neralie and Baker, Rohan and Millar, Douglas},
title = {The Application of 3base™ Technology to Diagnose Eight of the Most Clinically Important Gastrointestinal Protozoan Infections},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13387},
doi = {10.3390/ijms241713387}
}
EUVIMED